Area of research
Pharmacology · Molecular Medicine
Research interest
Research focused on Pharmacokinetics and Dosing, with related work in Adverse effect, Volume of distribution, Tolerability. Notable publications include 'Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics', 'Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects', and 'Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses'.
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects
Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses